Premios Avonni: Fármaco chileno contra la obesidad y síndrome metabólico

from 24 Horas | Showcast - Noticias 24 - Podcast · host 24 Horas | Showcast

La obesidad y el síndrome metabólico causan 4,7 millones de muertes anuales, además de un alto costo a nivel global. THANI BIOTECHNOLOGIES desarrolló un fármaco innovador para tratar la diabetes del síndrome metabólico que reduce el peso corporal, la grasa visceral y la glicemia. Carlos Fardella, director del Centro Traslacional de Endocrinología de la Facultad de Medicina de la Universidad Católica, ganador del premio Avonni Salud 2024, habló con 24 Horas.

Episode metadata supplied by the publisher feed · Published Aug 7, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Premios Avonni: Fármaco chileno contra la obesidad y síndrome metabólico

0:00 9:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 24 Horas | Showcast - Noticias 24 - Podcast?

This episode is 9 minutes long.

When was this 24 Horas | Showcast - Noticias 24 - Podcast episode published?

This episode was published on August 7, 2025.

Can I download this 24 Horas | Showcast - Noticias 24 - Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!